Many women suffer from recurrent vaginal yeast infections. It is unclear why some women are more sensitive to this than others. Researchers at Radboud university medical center discovered that mutations in the SIGLEC15 gene play an important role in this. These mutations disrupt the immune response, wrote the researchers in Science Translational Medicine, published on 12 June.Publication: Martin Jaeger et all. A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Science Translational Medicine.
Almost all women will suffer from a vaginal yeast infection at one time in their life. It is rarely dangerous, but it can be stressful because of the itching and pain. The culprit is the fungus Candida albicans, which occurs naturally in warm damp places in the body, along with numerous other bacteria and fungi. Normally, the Candida fungus is quite harmless, but if the natural balance between the microorganisms is disturbed, it can start to grow rampant, resulting in infections.
In three to eight percent of women, these infections recur regularly, on average three times a year. These infections are perfectly treatable, time after time, but there is no definitive solution to this recurring problem. The question as to why some women are sensitive to these infections remains unanswered. Diabetes may play a role in this, just as long-term use of antibiotics or contraceptive pills, but none of these risk factors apply to the majority of women with recurrent infections. The properties of the fungus itself do not provide a conclusive explanation either.
It may be possible that some women have a genetic predisposition to getting yeast infections. This has been researched before, but only on the basis of a few predefined genes that play a role in the immune response to Candida. This yielded only very few unambiguous results, which is why Martin Jaeger and his colleagues at Radboud university medical center compared the complete genetic profile of 155 women with and 172 women without susceptibility to Candida infections. They discovered that the SIGLEC15 gene plays an important role. “This gene isn't very well known,” explains Jaeger, “so relatively little research has been done. “
The SIGLEC15 gene is active in various immune cells. It produces so-called lectin proteins that can bind to sugar molecules, including sialic acid that is located on the outside of fungal cells. As soon as lectin adheres to the fungus, the immune system can recognise and clean up the fungus. Jaeger: “Due to a defect in the SIGLEC15 gene, the immune cells do not recognise the fungus, and it can continue to grow. This causes more immune cells, but because they still do not recognise the fungus, it keeps coming back. This cycle keeps coming back, which means that the symptoms are not caused by a lack of immune cells, but rather a surplus of them.”
The discovery of the SIGLEC15 gene provides more information about the cause of yeast infections, but does not offer a complete explanation, says Jaeger: "There are probably multiple genes involved in recurrent vaginal yeast infections. Not everyone with this SIGLEC15 gene mutation automatically gets infections. Many factors play a role, but we have now found an important factor that plays a role in recognising the Candida fungus.
For the treatment of vaginal yeast infections, it remains important to inhibit the immune system's overreaction, but Jaeger thinks it is difficult to cure the ailment definitively. “Because there is a genetic component to it, which - unfortunately - is difficult to eliminate.”
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
Careful prescription of addictive painkillers still necessary19 September 2019
Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.read more
Exercising at home has a positive effect on Parkinson's patients19 September 2019
In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.read more
A personal touch of Kartika Hapsari18 September 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.read more